title: Concerns for Development After Bevacizumab Treatment of ROP.
authors.affiliation: Division of Ophthalmology, The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; and quinn@email.chop.edu.
authors.forename: Graham E
authors.initials: GE
authors.lastname: Quinn
authors.affiliation: Department of Paediatrics, University of Otago, Christchurch, New Zealand.
authors.forename: Brian A
authors.initials: BA
authors.lastname: Darlow
mesh_terms: D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005865:Gestational Age; D006801:Humans; D058449:Intravitreal Injections; D012178:Retinopathy of Prematurity
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab